why choose us

Clinical Trials Search

Showing 14,780 of 132,656 result(s)
Criticality, Working Memory, and Effort

Status: COMPLETED

Condition: Healthy

Interventions:

The study intervention is modulation of cortical excitation to inhibition (E;I) balance in the dorsolateral prefrontal cortex (dlPFC) by means

Date: 2023-02-17

Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

Status: Completed

Condition: Diffuse Intrinsic Pontine Glioma

Interventions: Courses of weekly intravenous SC-CAR4BRAIN infusions for 3 weeks, then 1 week off

Date: 2023-02-17

Phase 1;2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)

Status: Completed

Condition: FSHD

Interventions: AOC 1020 will be administered via intravenous (IV) infusion

Date: 2023-02-17

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)

Status: Completed

Condition: Covid19

Interventions: Interventional

Date: 2023-02-17

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivmermectin 400)

Status: Completed

Condition: Covid19

Interventions: Interventional

Date: 2023-02-17

Anti-COVID-19 Vaccine Side Effects

Status: Completed

Condition: Vaccine Adverse Reaction
Gender
COVID-19 Vaccine Adverse Reaction

Interventions: Not Provided

Date: 2023-02-17

Study of a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face (FaceHyal)

Status: COMPLETED

Condition: Volume Deficiency in the Mid-Face

Interventions:

Up to 2.0 mL will be injected in the zygomaticomalar region and optionally up to 2.0 mL in the anteromedial cheek at the first session, on each sid

Date: 2023-02-17

A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults

Status: COMPLETED

Condition: COVID-19

Interventions: CVXGA is a live viral vector, consisting of a recombinant parainfluenza virus type 5 that carries the SARS-CoV-2 S-protein from WA.1 (not enrolling) o

Date: 2023-02-17

SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)

Status: COMPLETED

Condition: Retinal Disease

Interventions: IRX-101 is a novel ocular anti-septic

Date: 2023-02-17

Endoscopic Drainage of Presumed Resectable pCCA Using an Intrahepatic Plastic Stent With Retrieval String

Status: COMPLETED

Condition: Perihilar Cholangiocarcinoma

Interventions: DEVICE: Intrahepatic biliary stent with retrieval string - Plastic biliary stent with 3-0 nylon (ethilon) thread tied to the distal end of the stent t

Date: 2023-02-16